OPERATIONAL TEAM

  • france

    Anne-laure morel

    CEO . CSO . CO-FOUNDER

    • PhD in material chemistry, Paris Sorbonne University, HDR
    • Executive MBA, ESCP Europe business school

  • SWITZERLAND

    PROF. MICHELE DIANA

    CMO

    • PhD in medical sciences, Strasbourg University, MD, HDR
    • MBA, Insea Business School
    • Surgical Innovation Officer at University Hospital of Geneva
    • General surgeon, visiting professor at University of Geneva

  • USA

    RAFAEL ALVA

    CFO

    • MBA Carnegie Mellon University, Pittsburgh PA, USA
    • Over 25 years of expertise in corporate finance
    • Kyocera, Intel, Johnson & Johnson, and Procter & Gamble

  • AUSTRALIA

    NICOLAS MOREL

    COO

    • MSc in Physics & Nanotechnology (University of Montpellier II)
    • MBA (Quantic School of Business and Technology)
    • Global executive leadership with a track record in strategy, operations, business development, and international market expansion.

  • USA

    GLORIA MACEIKO, MS

    • San Francisco, California Founder CEO of Silicon Valley Advantage accelerator

  • USA

    THOMAS F. KROL, BS

    • PharmD, RPh, CLP

  • CANADA

    SHABNAM VAEZZADEH, MD, MPA, BCMAS

    • Medical and go to market expertise

SCIENTIFIC BOARD

  • AUSTRALIA

    PR. DIONA L. DAMIAN, MBBS, PHD

    • Principal investigator in Sydney melanoma Institute

    • Dermatologist

  • FRANCE

    PR. JEAN-LUC PERROT, PUPH, MD

    • Principal investigator in CHU ST Etienne
    • Oncodermatologist Specialist of medical imaging LC-OCT

  • FRANCE

    PR. LAURENT MORTIER, PUPH, MD

    • Principal investigator in CHU Lille
    • Oncodermatologue

  • FRANCE

    PR. ANTOINE BERTOLOTTI, PUPH, MD

    • CHRU Réunion & Kirby institute UNSM Sydney
    • Dermatologist

  • FRANCE

    PROF. EMERITUS PATRICK COUVREUR

    • Paris Saclay University - France

    • Pioneer in nanomedicine

  • ITALY

    PR. GIOVIANI TOSI

    • University of Modena and Regio Emilia- Italy

    • Nanomedicine & Pharmacology

  • USA

    DR. OHARA AIVAZ, MD

    • Cedars-Sinai Medical group, Beverly Hills, California

    • Dermatologist

  • FRANCE

    PR. NICOLAS MOLINARI, PUPH

    • CHU Montpellier - France

    • Methodologist / biostatistician

  • NEW ZEALAND

    DR. PAUL HAMILTON

    • Early phase clinical director
    • B.Sc, BHB, MBChB